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Abstract : The assessment of non-invasive parameters for the prediction of large esophageal varices among patients 
with liver cirrhosisis is of utmost importance. In this study, non-invasive parameters for prediction of large 
esophageal varices were retrospectively evaluated. The presence of esophageal varices grade III and IV was classified 
as large esophageal varices positive while no varices or grade I and II were classified as large esophageal varices 
negative. There were 473 (90.09%) patients with ascites [mild 38 (8.03%), moderate 257 (54.33%) and severe 178 
(37.63%)]. Frequency of esophageal varices was found to be higher (n=415, 79.04%). Whereas, large esophageal 
varices were found in 251 (47.81%) patients. The sensitivity, specificity, positive predicted value, negative predicted 
value and test accuracy of thrombocytopenia in predicting large esophageal varices were found to be 88.05%, 
59.85%, 66.77%, 84.54% and 73.33% respectively. A significant association for large esophageal varices was 
observed for low platelet counts (AOR : 0.98, 95% CI : 0.97-0.99), high bilirubin level (AOR : 1.22, 95% CI : 1.07-1.39), 
ascites (AOR : 1.98, CI : 1.02-3.85) and Child score A (AOR : 0.26, 95% CI : 0.09-0.75) and Child Score B (AOR : 0.42, 
95% CI : 0.28-0.61). In conclusion, low platelet count, high bilirubin level and ascites are found to be non-invasive 
predictive factor for large esophageal varices. J. Med. Invest. 66 : 248-251, August, 2019
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INTRODUCTION
 
Esophageal varices are a big challenge in managing cirrhotic 
patients and suggest its early detection with either invasive or 
non-invasive methods. (1) 
Various studies have evaluated the non-invasive predicting 
markers for large esophageal varices (LEVx) (2-5). Advanced 
Child-Pugh score, platelet count, serum albumin level, spleno-
megaly and increase portal vein diameter at ultrasonography 
are reported by several studies as the possible useful markers 
(6-8).It is stated that due to the disparities in the etiology 
and severity of liver cirrhosis and because of the nutritional 
status differences, these non-invasive prognostic factors showed 
variations when studied in different populations (8). Frequent 
hospitalizations due to the complications including the variceal 
bleeding are owing to late presentation of cirrhotics in our coun-
try (9).
American Association for the Study of Liver Disease (AASLD) 
and American College of Gastroenterology (ACG) practice guide-
lines have stated that upper GI endoscopy should be performed 
in all patients with liver cirrhosis to rule out LEVx. If the patient 
is found positive for having LEVx, treatment with β-adrenergic 
receptor antagonists should be started (10). Though long-term 
administration of β-adrenergic receptor antagonists in patients 
with LEVx reduces the incidence of first variceal bleeding, 
adverse effects are largely reported from its prolonged adminis-
tration (11). In addition, its use is not recommended in patients 
with small esophageal varices (11, 12).
Consequently, LEVx screening not only generates a huge 
burden on endoscopic units but is also a financial constraint on 
liver cirrhotics. Keeping the social, financial, and healthcare 
resource burdens implicated by these recommendations, recent 
studies have focused on the utility of non-invasive approaches to 
identify patients with LEVx, thereby, preventing the endoscopy 
of patients with lower risk (3-5, 8).
 
METHODOLOGY 
A retrospective study at Civil Hospital Karachi (CHK) was 
conducted from 2012 to 2016 after taking ethical approval (IRB-
878/DUHS/2017/78) from Dow University of Health Sciences 
(DUHS).
Diagnosis
Cirrhosis was confirmed on clinical (stigmata of chronic liver 
disease), biochemical and radiological (abdominal ultrasound or 
computerized tomography) parameters. Radiological features 
demonstrated small shrunken liver and intra-abdominal varices 
with or without enlarged spleen. Cirrhosis was also confirmed on 
a histopathological basis, wherever required (13).
Gastroesophageal varices were defined and classified in accor-
dance to Dagradi classification (14). Varices with blue or red in 
color and brought out by compression of the esophageal wall with 
the tip of the oesophagoscope were defined as grade 1. Grade 1 
varices are usually linear, maybe sigmoid shaped having less 
than 2 mm in diameter. Grade 2 varices were defined as bluish, 
mildly tortuous or straight, and were elevated above the surface 
or the relaxed esophagus having 2-3 mm in diameter. Grade 3 
were vividly elevated bluish veins either straight or tortuous 
having 3-4 mm in diameter. Tortuous bluish varices having > 4 
mm in diameter, which completely occupies the esophageal 
lumen closely packed around the wall and may or may not have 
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a good mucosal cover defined as Grade 4. Varices grape-like in 
appearance, obstructing the lumen of the approaching oesopha-
goscope with presence of small, cherry-red varices overlying the 
large, slightly deeper lying, slate blue-grey varices (also known 
as ‘varices over varices’) were defined as grade 5.
Those patients with the presence of hepatocellular carcinoma 
(HCC), portal hypertension surgery, history of esophageal var-
iceal bleeding, on primary prophylaxis treatment for variceal 
bleeding, sclerotherapy and/or portal vein thrombosis (PVT) 
were excluded to control the factors affecting the platelet count. 
Data collection
A detailed demographic and clinical information including 
age, gender, hematological and biochemical findings, liver dis-
ease severity, and ascites were recorded. The severity of the liver 
disease was noted on the basis of Child-Pugh Score whereas 
ascites was graded as none, mild, moderate and severe. Labo-
ratory findings were evaluated using hemoglobin (Hb) count, 
platelet count, total leukocyte count (TLC), serum concentration 
of albumin, bilirubin, alkaline phosphate (ALP), and alanine 
aminotransferase (ALT). The seropositivity of hepatitis B and C 
virus were also evaluated with patient’s history of alcohol intake 
and intravenous drug abuse. 
Abdominal ultrasonography with high-resolution real-time ul-
trasound machines was performed in all patients using GE Volu-
son S8 and Xario 100, Toshiba using 3.5-MHz convex transducer. 
Endoscopy of the upper gastrointestinal system was performed 
using one endoscopic unit (Olympus Corporation, Tokyo, Japan).
The presence of esophageal varices grade III & IV was clas-
sified as LEVx positive while no varices or grade I & II were 
classified as LEVx negative.
Statistical analysis
The mean and standard deviation for quantitative variables 
like age, Hb level, platelets count, TLC, Albumin, Bilirubin, ALP, 
and ALT was calculated while frequency and percentages for 
quantitative variables like gender, ascites, and the Child-Pugh 
score were calculated. Differences in the mean values of quanti-
tative variables were explored using independent t-test while to 
check the relationship in between LEVx and quantitative vari-
ables, chi-square test was applied. P-value < 0.05 was considered 
significant.    
The significant association between various independent 
variables and outcome variable (LEVx) were also explored using 
univariate binary logistic regression. All significant variables 
in univariate analysis were selected for multiple logistic regres-
sions to calculate adjusted odds ratio (AOR). 
Diagnostic accuracy was calculated using the standard throm-
bocytopenia level (150,000) as cut-off point of platelets counts.  
RESULTS
Initially, 600 patients were included. However, 75 patients 
were excluded because of the presence of HCC and/or history of 
esophageal variceal bleeding and portal vein thrombosis. Thus, 
in the final analysis, 525 cases were selected. The mean age was 
reported as 46.44 ± 14.43 years. Majority of the patients (n = 279, 
53.14%) were males. HCV virus was the predominant hepatic 
cirrhosis etiology reported in 396 (75.42%) patients, whereas 
HBV virus was found in 57 (10.85%), Cryptogenic 41 (7.81%), 
Wilson’s Disease 14 (2.67%), autoimmune hepatitis 9 (1.71%), 
alcoholism 5 (0.95%), and both HBV and HCV were found in 3 
(0.57%) patients. There were 473 (90.09%) patients with ascites. 
Among these, mild ascites was observed in 38 (8.03%), moderate 
in 257 (54.33%) and severe in 178 (37.63%) patients. 
The endoscopic finding showed that esophageal varices were 
found in 415 (79.04%) patients. Out of these 415 esophageal var-
ices positive patients, “grade I” esophageal varices were observed 
in 48 (11.56%) patients, “grade II” in 116 (27.97%), “grade III” in 
202 (48.67%), and “grade IV” in 49 (11.81%) patients. There were 
251 (47.81%) patients with LEVx (grade III & IV) whereas 274 
(52.19%) patients with no LEVx.
The Child-Pugh score C was found in the majority (n = 328, 
62.47%) of the patients followed by Child-Pugh Score B in 178 
(33.90%) and Child-Pugh score A in 19 (3.62%) patients. 
Thrombocytopenia (platelet count below 150,000) was ob-
served in 331 (63.04%) patients whereas 194 (36.95%) patients 
were presented with normal platelet count (platelet count above 
150,000). A significant difference of esophageal varices was 
observed among patients with and without thrombocytopenia 
(p-value < 0.001). LEVx was found significantly higher (n = 221, 
66.8%) among patients with thrombocytopenia as compared to 
normal platelet count (n = 30, 15.5%) (p-value < 0.001). (Figure 
1) The sensitivity, specificity, PPV, NPV and test accuracy of 
thrombocytopenia in predicting LEVx was found to be 88.05%, 
59.85%, 66.77%, 84.54% and 73.33% respectively. (Table I)
The difference in majority of the variables were insignificant 
among patients with and without LEVx including age (p-value 
0.092), gender (p-value 0.442), Hb (p-value 0.175), TLC (p-value 
0.159), ALP (p-value 0.202), and ALT (p-value0.075). While, the 
platelet count (p-value < 0.001), Bilirubin (p-value < 0.001), pres-
ence of ascites (p-value 0.045) and Child-Pugh Score (p-value < 
0.001) were the only variables found significantly related with 
LEVx. (Table II)
The univariate analysis revealed that platelet counts 
(OR : 0.98, 95% CI : 0.97-0.99),Child score A (OR : 0.28, 95% 
CI : 0.98-0.79) and Child Score B (OR : 0.42, 95% CI : 0.29-0.61) 
Figure 1 :　Difference between occurrence of large size esophageal 
varices versus no large size esophageal varices in thrombocytopenic 
and non-thrombocytopenic patients (n = 525)
Table I :　Diagnostic accuracy of thrombocytopenia in predicting 
large esophageal varices (n = 525) 
Thrombocytopenia
Large scale esophageal varices
Yes No Total
Yes 221 110 331
No 30 164 194
Total 251 274 525
Sensitivity : 88.05%
Specificity : 59.85%
Positive Predicted Value (PPV) : 66.77% 
Negative Predicted Value (NPV) : 84.54%
Test Accuracy : 73.33%
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were less likely whereas bilirubin level (OR : 1.18, 95% CI : 1.06-
1.31) and presence of ascites (OR : 1.83, 95% CI : 1.01-3.34) were 
more likely to have LEVx. Similarly, on multivariate analysis 
(adjusted for platelet counts, bilirubin, ascites and Child-Pugh 
score), platelet counts (AOR : 0.98, 95% CI : 0.97-0.99),Child 
score A (AOR : 0.26, 95% CI : 0.09-0.75) and Child Score B 
(AOR : 0.42, 95% CI : 0.28-0.61) were less likely whereas biliru-
bin level (AOR : 1.22, 95% CI : 1.07-1.39) and presence of ascites 
(AOR : 1.87, 95% CI : 1.02-3.49) were more likely to have LEVx. 
(Table III)
DISCUSSION
This study has shown a higher proportion of patients with 
liver cirrhosis having LEVx. Low platelet counts, high bilirubin 
level, presence of ascites, severity of cirrhosis (CTP-A, and CTP-
B) were found to have predictive ability on univariate analysis. 
Earlier studies (2, 4, 15-17) have also shown an independent 
predictive ability of low platelet count in liver cirrhosis patients 
to predict LEVx.
A palpable or enlarged spleen is reported to be an important 
predictor in most of the studies (2, 6, 18-20). Various studies have 
recommended “platelet count/spleen diameter” (PC/SD) ratio as 
the most viable non-invasive tool in the prediction of the varices 
(4, 19-23). However, as this study is retrospective PC/SD ratio of 
our patients was not calculated. Though mostly earlier studies 
have shown PC/SD ratio as an effective non-invasive parameter 
for prediction of LEVx, but one local study in Pakistan has shown 
contrary findings (24) where PC/SD ratio could not reliably pre-
dict the esophageal varices in cirrhotic patients. Furthermore, 
above referred study (24) have also reported an insignificant 
association of low platelet count with esophageal varices. 
Low platelet count and ascites are widely reported as a nonin-
vasive predictor of esophageal varices by earlier published stud-
ies (25-31) which is in agreement to this study. Prior studies (32, 
33) have validated both clinical and sonologically determined 
ascites as an independent predictor for LEVx.
High level of serum bilirubin has shown a significant predic-
tor for LEVx in this study which is in accordance to an earlier 
study (29). Schwarzenberger et al. in their study reported various 
parameters like ascites, splenomegaly, serum albumin concen-
tration, Child score, and portal vein diameter as predictive vari-
ables for LEVx (30). Recently, Chen et al evaluated the combined 
effect of “albumin bilirubin grade and platelet count” to predict 
risk of large varices and variceal haemorrhage (5). Due to the 
diversity of liver diseases and variations in the characteristics 
among different populations earlier studies have shown different 
parameters to predict large esophageal varices. In fact, a highly 
accurate non-invasive predictive model for LEVx is still awaited 
(4).
Findings of this study could be ascertained in the light of the 
limitations that due to retrospective nature of the study, spleen 
diameter values of our patients were not collected. Thus, PC/
SD ratio of our patients was not evaluated which if determined 
would have a more statistical impact. However, to the best of our 
knowledge, this is the first study from Pakistan reporting the 
predicting factor for LEVx from such a larger population.
 
CONCLUSION
Low platelet count, high bilirubin level and presence of ascites 
can be used as independent non-invasive predictive factors for 
LEVx among patients with liver cirrhosis. Further validation of 
these non invasive parameters through large prospective studies 
in resource-limited areas like Pakistan where endoscopy is not 
available everywhere,would definitely provide a non invasive 
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